Finance News - Formulation

All U.S. UK Canada Australia Europe India Global Crypto

No results found

Type at least 2 characters to search

Loading tags...

No matching tags found

Filter by:

Any time Past hour Past 24 hours Past week Past month Past year

All Sources ABC News Business BBC Business Business Insider Markets City A.M. CNBC Business CoinDesk Coinpedia Cointelegraph Crypto News CryptoSlate Decrypt Economic Times Markets Euronews Business Financial Post Top Stories Financial Times Globe and Mail Investing Investing.com Global Mkts Investopedia Kiplinger MarketWatch MarketPulse MarketWatch Top Stories Quartz Sky News Money Sydney Morning Herald Biz TechCrunch Fintech The Block The Guardian – Business WSJ Markets News

All Access Types Free Limited Free Subscription Required

Category Formulation

Business Insider Markets • 06/03/2025 • Limited Free

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book

The newly granted patent for Biofrontera’s updated topical treatment extends intellectual property rights until 2043, potentially securing long-term r...

Read Full Article →

Price Alerts

Sign in to create alerts

Finance News - Formulation

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book

Featured Sources

What is your interest today?

Sign in to continue

Weekly limit reached

Export limit reached

Historical lookups used

Extended Charts - Pro Feature

Cloud Export - Pro Feature

Finance News - Formulation

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book

Featured Sources

What is your interest today?

Format Settings

Language

Localized Format

Decimal Format